Martin Haluzík Selected Research

Hormones (Hormone)

9/2020	The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus.
1/2011	[Hyperglycemia and its control in the critically ill patient].
1/2010	[Changes of plasma obestatin and ghrelin levels after soluble fiber with glucose and after fiber alone in healthy women and in patients with bulimia nervosa].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Haluzík Research Topics

Disease

29	Type 2 Diabetes Mellitus (MODY) 04/2024 - 09/2009
24	Obesity 01/2023 - 09/2006
16	Body Weight (Weight, Body) 03/2022 - 09/2008
12	Inflammation (Inflammations) 01/2023 - 11/2009
9	Hypoglycemia (Reactive Hypoglycemia) 04/2024 - 01/2013
8	Insulin Resistance 12/2022 - 09/2008
5	Weight Gain 04/2024 - 01/2012
4	Hyperglycemia 04/2024 - 09/2006
4	Weight Loss (Weight Reduction) 01/2022 - 12/2014
4	Rheumatoid Arthritis 10/2013 - 07/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 09/2014
3	Critical Illness (Critically Ill) 02/2024 - 01/2011
3	Chronic Renal Insufficiency 01/2024 - 11/2009
3	Diabetes Mellitus 04/2023 - 09/2014
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2022 - 01/2018
3	Atherosclerosis 10/2022 - 11/2009
3	Pheochromocytoma 03/2022 - 04/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 11/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 12/2016
3	Anorexia Nervosa 01/2018 - 09/2008
2	Paraganglioma (Paragangliomas) 03/2022 - 04/2019
2	Non-alcoholic Fatty Liver Disease 12/2021 - 11/2009
2	Heart Failure 01/2021 - 12/2014
2	Neoplasms (Cancer) 04/2019 - 11/2009
2	Short Bowel Syndrome 01/2018 - 02/2002
2	Dyslipidemias (Dyslipidemia) 12/2016 - 05/2012
1	Infections 01/2023
1	Neonatal Sepsis 01/2023
1	Sepsis (Septicemia) 01/2023
1	Neonatal Jaundice 10/2022
1	Fetal Macrosomia 10/2022
1	Glycosuria 01/2022
1	Fatty Liver 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Gilbert Disease 12/2021
1	Atrial Fibrillation 01/2021

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2009
11	Insulin (Novolin)FDA Link 04/2024 - 09/2008
10	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 12/2014
9	AdipokinesIBA 12/2021 - 07/2010
7	LipidsIBA 10/2020 - 12/2014
7	LeptinIBA 01/2020 - 09/2006
6	Insulin Glargine (Lantus)FDA Link 04/2024 - 01/2019
6	Liraglutide FDA Link 01/2022 - 01/2015
6	CytokinesIBA 11/2021 - 08/2010
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 12/2014
4	lixisenatideIBA 04/2024 - 04/2018
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022 - 07/2015
4	insulin degludecIBA 01/2020 - 01/2018
4	C-Reactive ProteinIBA 01/2019 - 09/2009
4	Sodium Glutamate (Accent)IBA 01/2016 - 09/2006
3	InsulinsIBA 01/2024 - 09/2014
3	semaglutideIBA 01/2022 - 01/2019
3	Hormones (Hormone)IBA 09/2020 - 01/2010
3	palm11-PrRP31IBA 01/2020 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2013
3	Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA 01/2018 - 01/2016
3	AdiponectinIBA 01/2016 - 09/2008
2	BilirubinIBA 10/2022 - 12/2021
2	CatecholaminesIBA 03/2022 - 01/2011
2	IDegLiraIBA 01/2020 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 05/2019 - 01/2016
2	VildagliptinIBA 05/2019 - 01/2016
2	fibroblast growth factor 21IBA 04/2019 - 09/2008
2	EnzymesIBA 01/2019 - 01/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 04/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
2	CholesterolIBA 01/2017 - 10/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 01/2017
2	HDL CholesterolIBA 01/2017 - 09/2009
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 09/2009
2	NeuropeptidesIBA 01/2016 - 09/2006
2	IncretinsIBA 12/2014 - 01/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012 - 01/2011
2	GhrelinIBA 01/2010 - 02/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Insulin-Like PeptidesIBA 12/2022
1	Carrier Proteins (Binding Protein)IBA 12/2022
1	AntioxidantsIBA 10/2022
1	neutral insulin FDA Link 03/2022
1	insulin aspart drug combination insulin degludecIBA 02/2022
1	TransferasesIBA 12/2021
1	Uridine Diphosphate (UDP)IBA 12/2021
1	Heme Oxygenase-1IBA 12/2021
1	empagliflozinIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2023 - 01/2011
5	Bariatric Surgery 01/2021 - 01/2016
3	Glycemic Control 03/2022 - 01/2011
3	Caloric Restriction 01/2018 - 09/2009
1	Organ Transplantation 02/2024
1	Drug Therapy (Chemotherapy) 01/2023
1	Induced Labor 10/2022
1	Phototherapy (Light Therapy) 10/2022
1	Gastrectomy 01/2021
1	Preconception Care 01/2021
1	Catheter Ablation 01/2021